Sign Up to like & get
recommendations!
0
Published in 2019 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2018.1528215
Abstract: Abstract Objective: In May 2018, the US Food and Drug Administration approved pegvaliase-pqpz (Palynziq*), the first enzyme substitution therapy for the treatment of phenylketonuria (PKU). This article provides an overview of the mechanism of action,…
read more here.
Keywords:
treatment option;
pegvaliase;
treatment;
pegvaliase novel ... See more keywords